Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M43,524Revenue (TTM) $M10,470Net Margin (%)15.3Altman Z-Score3.9
Enterprise Value $M47,512EPS (TTM) $4.2Operating Margin %19.5Piotroski F-Score6
P/E(ttm)27.4Beneish M-Score-2.0Pre-tax Margin (%)17.9Higher ROA y-yY
Price/Book4.810-y EBITDA Growth Rate %4.2Quick Ratio1.6Cash flow > EarningsN
Price/Sales4.25-y EBITDA Growth Rate %-1.2Current Ratio2.2Lower Leverage y-yN
Price/Free Cash Flow98.3y-y EBITDA Growth Rate %18.2ROA % (ttm)9.0Higher Current Ratio y-yN
Dividend Yield %1.3PEG--ROE % (ttm)18.5Less Shares Outstanding y-yY
Payout Ratio %35.0Shares Outstanding M374ROIC % (ttm)18.8Gross Margin Increase y-yY

Gurus Latest Trades with SYK

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SYKYacktman Fund 2016-06-30 Reduce-0.74%$107.04 - $119.83
($111.74)
$ 116.284%Reduce -31.25%1,100,000
SYKDonald Yacktman 2016-06-30 Reduce-0.46%$107.04 - $119.83
($111.74)
$ 116.284%Reduce -28.01%1,402,704
SYKRobert Olstein 2016-06-30 Reduce-0.1%$107.04 - $119.83
($111.74)
$ 116.284%Reduce -15.56%38,000
SYKGeorge Soros 2016-06-30 Sold Out -0.06%$107.04 - $119.83
($111.74)
$ 116.284%Sold Out0
SYKJoel Greenblatt 2016-06-30 Reduce-0.03%$107.04 - $119.83
($111.74)
$ 116.284%Reduce -25.47%63,965
SYKYacktman Fund 2016-03-31 Reduce-0.13%$87.53 - $107.29
($98.35)
$ 116.2818%Reduce -5.88%1,600,000
SYKJoel Greenblatt 2016-03-31 Buy 0.1%$87.53 - $107.29
($98.35)
$ 116.2818%New holding85,828
SYKRobert Olstein 2016-03-31 Reduce-0.08%$87.53 - $107.29
($98.35)
$ 116.2818%Reduce -13.46%45,000
SYKDonald Yacktman 2016-03-31 Reduce-0.08%$87.53 - $107.29
($98.35)
$ 116.2818%Reduce -5.46%1,948,574
SYKGeorge Soros 2016-03-31 Buy 0.06%$87.53 - $107.29
($98.35)
$ 116.2818%New holding20,300
SYKYacktman Focused Fund 2015-12-31 Sold Out -0.7%$91.26 - $100.46
($95.71)
$ 116.2821%Sold Out0
SYKDonald Yacktman 2015-12-31 Reduce-0.67%$91.26 - $100.46
($95.72)
$ 116.2821%Reduce -34.44%2,061,165
SYKYacktman Fund 2015-12-31 Reduce-0.35%$91.26 - $100.46
($95.71)
$ 116.2821%Reduce -15.00%1,700,000
SYKVanguard Health Care Fund 2015-12-31 Add0.2%$91.26 - $100.46
($95.72)
$ 116.2821%Add 74.32%2,498,900
SYKRobert Olstein 2015-12-31 Add0.04%$91.26 - $100.46
($95.72)
$ 116.2821%Add 6.12%52,000
SYKDodge & Cox 2015-12-31 Sold Out $91.26 - $100.46
($95.72)
$ 116.2821%Sold Out0
SYKYacktman Focused Fund 2015-09-30 Reduce-1.66%$92.4 - $104.53
($99.06)
$ 116.2817%Reduce -75.00%400,000
SYKDonald Yacktman 2015-09-30 Reduce-0.89%$92.4 - $104.53
($99.06)
$ 116.2817%Reduce -35.63%3,143,750
SYKYacktman Fund 2015-09-30 Reduce-0.4%$92.4 - $104.53
($99.06)
$ 116.2817%Reduce -16.67%2,000,000
SYKRobert Olstein 2015-09-30 Reduce-0.27%$92.4 - $104.53
($99.06)
$ 116.2817%Reduce -35.53%49,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SYK is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


SYK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
STRYKER RONDA EDirector 2016-08-24Sell12,000$113.530.8view
STRYKER RONDA EDirector 2016-08-22Sell12,000$113.820.54view
STRYKER RONDA EDirector 2016-08-18Sell12,000$113.071.21view
STRYKER RONDA EDirector 2016-08-16Sell12,000$114.86-0.37view
STRYKER RONDA EDirector 2016-08-12Sell12,000$115.54-0.95view
STRYKER RONDA EDirector 2016-08-10Sell12,000$115.4-0.83view
STRYKER RONDA EDirector 2016-08-08Sell12,000$114.40.03view
STRYKER RONDA EDirector 2016-08-04Sell12,000$115.24-0.69view
STRYKER RONDA EDirector 2016-08-02Sell12,000$116.37-1.66view
COX HOWARD E JRDirector 2016-08-01Sell9,448$117.02-2.2view

Quarterly/Annual Reports about SYK:

News about SYK:

Articles On GuruFocus.com
Johnson & Johnson Reports 4% Sales Growth for the Second Quarter Jul 22 2016 
Becton Dickinson: 19% EPS Growth With Good Dividends Jun 26 2016 
Answers to the Hardest Question: When Do I Sell a Stock? Jun 23 2016 
Weekly Insider Sells: Medivation, JPMorgan Chase, Stryker, Sabre Jan 26 2016 
Stryker: An Expensive Growth Play Dec 26 2015 
Louis Moore Bacon's Largest 3rd Quarter Trades Dec 23 2015 
Eric Mindich Sells Stakes in Catamaran and Alphabet in 3rd Quarter Dec 02 2015 
Weekly Insider Sells Highlights: Nike, Intuitive Surgical, Travelers Companies, Stryker Oct 26 2015 
Donald Yacktman Comments on Stryker and Anthem Aug 06 2015 
Yacktman Focused Fund 2nd Quarter 2015 Commentary Aug 05 2015 

More From Other Websites
ETF’s with exposure to Stryker Corp. : August 26, 2016 Aug 26 2016
Medovex Corporation Adds 35 Year Orthopedic Industry Veteran Ron Lawson to Board of Directors Aug 25 2016
Discussing Stryker’s Latest Valuation Aug 25 2016
A Look at Stryker’s Updated Guidance for 2016 Aug 24 2016
Analyzing SYK’s Capital Deployment Strategy for Investor Value Aug 24 2016
Stryker Continues to Exhibit a Strong Inorganic Growth Strategy Aug 24 2016
How Stryker Plans to Leverage the Under-Tapped Europe Opportunity Aug 24 2016
How MAKO Robots Could Contribute to SYK’s Orthopedics Growth Aug 24 2016
New Product Launches Drive Stryker’s Growth and Profitability Aug 24 2016
A Look at Stryker’s Consistently Growing Revenue Profile Aug 24 2016
Analysts’ Latest Recommendations for Stryker Aug 24 2016
STRYKER CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a... Aug 23 2016
ETF’s with exposure to Stryker Corp. : August 15, 2016 Aug 15 2016
Why Medical Devices ETF Is Among The Winners Of 2016 Aug 05 2016
ETF’s with exposure to Stryker Corp. : August 4, 2016 Aug 04 2016
Stryker Corp. :SYK-US: Earnings Analysis: Q2, 2016 By the Numbers : August 2, 2016 Aug 02 2016
Cramer: A speculative play on pot Jul 28 2016
STRYKER CORP Financials Jul 28 2016
Weak China sales drag down Smith & Nephew profits Jul 28 2016
AngioDynamics Issues Statement Regarding Stryker recall of Angiographic Catheters Jul 27 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)